Advoctech Health Solutions.
Close
- Vancouver, BC.
About Mark
Dr. Mark Tyndall MD, ScD, FRCPC
Professor of Medicine, School of Population and Public Health, University of British Columbia.
Dr. Mark Tyndall is a Professor of Medicine at the School of Population and Public Health, University of British Columbia. He has served as the Executive Director of the BC Center for Disease Control (2014-2018), deputy Provincial Health Officer for British Columbia (2014-2018), Head of Infectious Diseases at St. Paul’s Hospital, Vancouver (2004-2010) and the University of Ottawa (2010-2014), and Program Director for Epidemiology at the BC Centre for Excellence in HIV/AIDS (1999-2010).His career awards include the Medical Research Council Research Fellowship, Michael Smith Foundation for Health Research Senior Scholar Award, and the Ontario HIV Treatment Network Applied Research Chair. He has authored over 250 peer-reviewed academic publications, with a focus on HIV care and prevention, harm reduction, and public health intervention research.
Dr. Tyndall received his medical degree and Internal Medicine training at McMaster University and his Infectious Diseases fellowship training at the University of Manitoba. He received a Doctoral Degree in Epidemiology from The School of Public Health at Harvard University with a focus on health and human rights. He was a research scientist at the WHO Collaborative HIV Program in Nairobi, Kenya from 1990 to 1995.
He has conducted numerous community-based research projects and was the co-lead investigator on the evaluation of Insite, North America’s first supervised injection site. Other major research interests include the epidemiology of HIV and Hepatitis C, the impact of harm reduction interventions, and antiretroviral access and barriers to health care among people who use drugs, and the drug overdose epidemic.
Dr. Tyndall is a strong advocate and leader for public health in Canada and has fostered a number of community-based collaborations that have led to health policy changes including the scale of harm reduction programs, health care access for refugees, decriminalization of HIV transmission, and vaping regulations.
Dr. Mark Tyndall has an international reputation as a leader who takes on difficult issues and produces results. His work has always been grounded in compassion, human rights, and health equity.
VAPING
Behind the Smoke and Fears
There are more than one billion smokers in the world and the vast majority will die prematurely because of their nicotine addiction. What most people don’t know is that there is a cure: vaping. Vaping is a non-toxic way to deliver the nicotine that people need without the disease-producing byproducts of burning tobacco. Compared with cigarettes, any health risks associated with vaping are very small. Yet incredibly, most tobacco control officials, public health organizations, and politicians view vaping as a threat, advocating for restrictions or outright bans.
